Inter Parfums Insider Files Form 144 for $53K Stock Sale

Rhea-AI Filing Summary

Inter Parfums, Inc. (IPAR) has filed a Form 144 notice with the U.S. Securities and Exchange Commission.

The filing discloses a proposed sale of 400 common shares through Oppenheimer & Co. at an aggregate market value of $53,429. The shares were originally acquired on 17 Jan 2025 as compensation. The filer intends to execute the sale on or about 23 Jun 2025 on the NASDAQ exchange.

According to the notice, Inter Parfums has 32.124 million shares outstanding; therefore, the planned disposition represents approximately 0.001 % of the total share count. No additional sales have been reported during the prior three-month period, and no remarks or signatures were included in the excerpt provided.

The Form 144 also contains the standard representation that the seller is unaware of any undisclosed material adverse information regarding the issuer.

Insights

Financial Analyst

TL;DR: Minor Form 144—400 shares (~$53k) vs. 32 m float; negligible impact, routine insider liquidity.

The notice details a small prospective insider sale valued just above the $50 k reporting threshold. While Form 144 signals potential insider activity, the volume—400 shares—equates to roughly 0.001 % of outstanding stock, far below levels considered price-sensitive. The shares were awarded as compensation earlier this year, suggesting normal monetisation of equity incentives. No concurrent sales in the last three months and no adverse disclosures accompany the filing. Given the immaterial size, the event is neutral for valuation or trading dynamics. Investors typically monitor larger insider dispositions or clustered selling for sentiment cues; this isolated, modest transaction does not alter the investment thesis for IPAR.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Oppenheimer & Co Inc 85 Broad Street New York NY 10004	400	53429.00	32124000	06/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	01/17/2025	compensation	Issuer			400	01/17/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Inter Parfums (IPAR) shares are proposed for sale in the Form 144?

400 common shares are slated for sale.

What is the aggregate market value of the shares in this IPAR Form 144 filing?

The 400 shares have an aggregate market value of $53,429.

When is the planned sale date for the IPAR shares?

The approximate sale date listed is 23 June 2025.

Which broker will execute the IPAR share sale?

The proposed broker is Oppenheimer & Co. Inc., 85 Broad Street, New York, NY 10004.

How significant is the sale relative to IPAR’s shares outstanding?

400 shares represent about 0.001 % of the 32.124 million shares outstanding, indicating an immaterial impact.